Using patient-reported symptoms of dyspnea for screening reduced respiratory function in patients with motor neuron diseases.
Jochem HellemanEsther T Kruitwagen-van ReenenJ BakersWilleke J KruithofAnnerieke C van GroenestijnRineke J H Jaspers FocksArthur de GrundLeonard H van den BergJohanna M A Visser-MeilyAnita BeelenPublished in: Journal of neurology (2020)
The diagnostic performance of the MND-DS was better than the respiratory domain of the ALSFRS-R for screening reduced respiratory function in patients with MND, and is, therefore, the preferred method for (remotely) monitoring respiratory function.